Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The JointJYNT +0.66%62 Equity-to-Asset is 0.27 as of Mar. 2026, which is 7% below its 10-year median of 0.29. GuruFocus rates JYNT with a GF Score™ of 62/100 and a GF Value™ of $11.27 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 683 Healthcare Providers & Services companies, The Joint ranks worse than 75.26% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. The Joint's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $15.47 Mil. The Joint's Total Assets for the quarter that ended in Mar. 2026 was $57.92 Mil.
Therefore, The Joint's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.27.
The historical rank and industry rank for The Joint's Equity-to-Asset or its related term are showing as below:
JYNT'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.03 Med: 0.29 Max: 0.58
Current: 0.27
During the past 13 years, the highest Equity to Asset Ratio of The Joint was 0.58. The lowest was 0.03. And the median was 0.29.
JYNT's Equity-to-Asset is ranked worse than 75.26% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 0.48
vs JYNT: 0.27
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
The Joint Equity-to-Asset Related Terms
The Joint Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for The Joint's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JYNT vs WW, PARK, BTMD: Equity-to-Asset Comparison
For the Medical Care Facilities subindustry, The Joint's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Joint Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, The Joint's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where The Joint's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
The Joint's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Joint (JYNT) has a Equity-to-Asset of 0.27 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on The Joint and its competitors. This is near median its historical median of 0.29. Over the past decade, The Joint's Equity-to-Asset has ranged from 0.03 to 0.58. According to the industry distribution chart, The Joint ranks #514 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 75.3%.
Is The Joint's Equity-to-Asset too high?
The Joint's current Equity-to-Asset of 0.27 is near median its 10-year median of 0.29. Over the past 10 years, this metric has ranged from a low of 0.03 to a high of 0.58. The Healthcare Providers & Services industry median Equity-to-Asset is 0.48. The Joint's value of 0.27 is 43.8% below this industry median. Based on the distribution chart, The Joint ranks #514 out of 683 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, The Joint has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Joint's Equity-to-Asset compare to WW and PARK?
According to the Healthcare Providers & Services industry distribution chart, The Joint ranks #514 out of 683 companies for Equity-to-Asset. This places The Joint in the lower half of its industry. The industry median Equity-to-Asset is 0.48. The Joint's value of 0.27 is 43.8% below this benchmark. Historically, The Joint's own Equity-to-Asset has ranged from 0.03 to 0.58 over the past decade. While the company's 10-year median is 0.29 vs. the industry median of 0.48, The Joint has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Joint's current Equity-to-Asset of 0.27 is 43.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on The Joint and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Joint's current Equity-to-Asset is 0.27, which is near median its own 10-year median of 0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Joint stock overvalued right now?
Based on GuruFocus' analysis, The Joint (JYNT) is currently considered Modestly Undervalued. The stock's GF Value™ is $11.27, compared to a current price of $8.43 — trading 25.2% below its estimated fair value. The current Equity-to-Asset is 0.27, which is near median its 10-year median of 0.29 and 43.8% below the Healthcare Providers & Services industry median of 0.48. The Joint's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For The Joint (JYNT), the current Equity-to-Asset is 0.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Joint (JYNT) Overvalued in 2026?
Based on GuruFocus' analysis, The Joint stock appears to be undervalued.
The current stock price of $8.43 is trading 25.2% below its estimated GF Value™ of $11.27.
GuruFocus considers The Joint to be Modestly Undervalued.
Key valuation signals for JYNT:
Equity-to-Asset: 0.27 (near median its 10-year median of 0.29)
GF Value™: $11.27 vs. price of $8.43 (25.2% below fair value)
Industry Position: 43.8% below the Healthcare Providers & Services median (#514 of 683)
No single metric tells the full story. See the JYNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.
62GF Score
Get the complete analysis for JYNT
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JYNT has been successfully added to your 
